This page lists the SEC filings reported by GENERAL ATLANTIC, L.P..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-03-15 | GENERAL ATLANTIC, L.P. | Akero Therapeutics, Inc. | 5,233,989 | 7.7% | EDGAR |
| SC 13D/A | 2024-03-07 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 1,747,849 | 3.5% | EDGAR |
| SC 13D/A | 2024-02-16 | GENERAL ATLANTIC, L.P. | HireRight Holdings Corp | 32,137,852 | 47.7% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Blend Labs, Inc. | 19,132,440 | 8.0% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | BuzzFeed, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Mobileye Global Inc. | 1,318,782 | 1.4% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Pharvaris N.V. | 7,531,252 | 14.1% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Samsara Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Clear Secure, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Royalty Pharma plc | 26,259,141 | 5.6% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Grove Collaborative Holdings, Inc. | 2,710,025 | 8.2% | EDGAR |
| SC 13G/A | 2024-02-13 | GENERAL ATLANTIC, L.P. | Squarespace, Inc. | 15,586,169 | 16.7% | EDGAR |
| SC 13D/A | 2023-12-11 | GENERAL ATLANTIC, L.P. | Arco Platform Ltd. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-12-08 | GENERAL ATLANTIC, L.P. | HireRight Holdings Corp | 32,137,852 | 47.5% | EDGAR |
| SC 13D/A | 2023-11-17 | GENERAL ATLANTIC, L.P. | HireRight Holdings Corp | 32,137,852 | 47.5% | EDGAR |
| SC 13D/A | 2023-09-25 | GENERAL ATLANTIC, L.P. | Fang Holdings Ltd | 11,106,440 | 16.8% | EDGAR |
| SC 13D/A | 2023-09-18 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 2,606,684 | 5.3% | EDGAR |
| SC 13D/A | 2023-08-14 | GENERAL ATLANTIC, L.P. | Arco Platform Ltd. | 5,827,504 | 14.3% | EDGAR |
| SC 13D/A | 2023-07-11 | GENERAL ATLANTIC, L.P. | XP Inc. | 29,617,733 | 7.1% | EDGAR |
| SC 13G/A | 2023-06-23 | GENERAL ATLANTIC, L.P. | Pharvaris N.V. | 4,406,252 | 10.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.